BHTP Advises Syner-G Pharma Consulting, LLC in Strategic Transaction

BOSTON – Blais Halpert Tax Partners LLP represented Syner-G Pharma Consulting, LLC in a strategic transaction with private equity firm Riverside Partners that closed on October 28. Travis Blais led Syner-G’s tax team, working closely with M&A advisory firm Network Blue, Inc., led by John Hallal. It’s the latest in a long series of buyouts, investments, financings, and other strategic transactions that Blais Halpert Tax Partners has helped close on behalf of pharmaceutical, biotechnology, and other life science industry clients.

Syner-G, led by Prabu Nambiar and Binesh Prabhakar, is a leading provider of customized science and risk-based CMC technical, regulatory and compliance solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. With its high customer retention, Syner-G oversees all aspects of CMC technical, regulatory and compliance services throughout the drug development process and post-commercialization.

Blais Halpert Tax Partners LLP is a Boston-based transactional tax law boutique focused on tax-sensitive structuring and implementation of high-value business transactions, including mergers and acquisitions, growth company startup and financing, private equity and venture capital investments, fund formations, real estate, and executive compensation arrangements. A cornerstone of our practice is serving as tax co-counsel to corporate lawyers who need top-tier tax support for their clients’ business transactions.

Network Blue, Inc. is a Massachusetts-based M&A advisory firm that aims to combine in one service all of the key aspects of a sale or purchase of a business. These include financial advisory, negotiations, due diligence, and legal guidance. For over 10 years, NBI has deployed its broad expertise in numerous middle market transactions.